Sumsuzzman D M, Wang Z, Langley JM, Moghadas SM, Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: A systematic review and meta-analysis, The Lancet Child & Adolescent Health 2025, 9: 393-403.
Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 31(2): 647-652.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Mostaco–Guidolin LC, Bowman CS, Greer AL, Fisman DN, Moghadas SM, Transmissibility of the 2009 H1N1 pandemic in remote and isolated Canadian communities: a modelling study, British Medical Journal Open 2012, 2: e001614.
Duvvuri VRSK, Heffernan JM, Moghadas SM, Duvvuri D, Guo H, Fisman DN, Wu J, Wu GE, The Role of cellular immunity in Influenza H1N1 population dynamics, BMC Infectious Diseases 2012, 12: 329.
Richardson K, Driedger SM, Pizzi NJ, Wu J, Moghadas SM, Indigenous populations health protection: a Canadian perspective, BMC Public Health 2012, 12: 1098.
Moghadas SM, Pizzi NJ, Wu J, Tamblyn SE, Fisman DN, Canada in the face of the 2009 H1N1 pandemic, Influenza and Other Respiratory Viruses 2011, 5: 83–88.
Laskowski M, Mostaco–Guidolin LC, Greer AL, Wu J, Moghadas SM, The impact of demographic variables on disease spread: influenza in remote communities, Scientific Reports 2011, 1; 105: 1–7.
Mostaco–Guidolin LC, Pizzi NJ, Moghadas SM, A classical approach for estimating the transmissibility of the 2009 H1N1 pandemic, Canadian Applied Mathematics Quarterly 2011, 19: 185–194.
Mostaco–Guidolin LC, Greer AL, Sander B, Wu J, Moghadas SM, Variability in transmissibility of the 2009 H1N1 pandemic in Canadian communities, BMC Research Notes 2011, 4: 537.
Bowman CS, Arino J, Moghadas SM, Evaluation of vaccination strategies during pandemic outbreaks, Mathematical Biosciences and Engineering 2011, 8: 117–125.
Wessel L, Hua Y, Wu J, Moghadas SM, Public health interventions for epidemics: implications for multiple infection waves, BMC Public Health 2011, 11 (Suppl 1): S2.
Arino J, Bauch CT, Brauer F, Driedger SM, Greer AL, Moghadas SM, Pizzi NJ, Sander B, Tuite A, van den Driessche P, Watmough J, Wu J, Yan P, Pandemic influenza: modelling and public health perspectives, Mathematical Biosciences and Engineering 2011, 8: 1–20.